TORC1‐dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective: Seizure development in tuberous sclerosis complex (TSC) correlates with the presence of specific lesions called cortical tubers. Moreover, heterozygous TSC animal models do not show gross brain pathology and are seizure‐free, suggesting that such pathology is a prerequisite for the development of epilepsy. However, cells within TSC lesions show increased activity of the target of rapamycin complex 1 (TORC1) pathway, and recent studies have implicated this pathway in non–TSC‐related animal models of epilepsy and neuronal excitability. These findings imply a direct role for TORC1 in epilepsy. Here, we investigate the effect of increased TORC1 signaling induced by acute biallelic deletion of Tsc1 in healthy adult mice. Methods: Biallelic Tsc1 gene deletion was induced in adult Tsc1 heterozygous and wild‐type mice. Seizures were monitored by electroencephalographic and video recordings. Molecular and cellular changes were investigated by Western blot analysis, immunohistochemistry, and electrophysiology. Results: Mice developed epilepsy a few days after biallelic Tsc1 deletion. Acute gene deletion was not accompanied by any obvious histological changes, but resulted in activation of the TORC1 pathway, enhanced neuronal excitability, and a decreased threshold for protein‐synthesis–dependent long‐term potentiation preceding the onset of seizures. Rapamycin treatment after seizure onset reduced TORC1 activity and fully abolished the seizures. Interpretation: Our data indicate a direct role for TORC1 signaling in epilepsy development, even in the absence of major brain pathology. This suggests that TORC1 is a promising target for treating seizures not only in TSC but also in other forms of epilepsy that result from increased TORC1 activation. Ann Neurol 2013;74:569–579
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“Nonetheless, 4 days after Tsc1 deletion, TSC1 was still present at 25% of wild-type levels, consistent with an estimated protein half-life> 48 hours.(24) Tamoxifen-injected Tsc1 mice also showed a significant decrease of TSC2 levels in hippocampus, cortex, and cerebellum (see Fig 2, Supplementary Fig 1A, B), confirmin…”
ResultThe Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882 · cited 4×
“The changes in L-LTP are in line with the role of TORC1 signaling in the protein-synthesis phase of LTP.8,28 Passive membrane properties, such as RMP and RIN, were normal in the Tsc1f/2 mutant cells, suggesting that the hyperexcitability and reduced threshold for eliciting APs may result from changes in the expression…”
BackgroundMethodInfluentialTang, S. J., Reis, G., Kang, H., Gingras, A.-C., Sonenberg, N., & Schuman, E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012605299 · Cited by 734 · cited 5×
“The changes in L-LTP are in line with the role of TORC1 signaling in the protein-synthesis phase of LTP.8,28 Passive membrane properties, such as RMP and RIN, were normal in the Tsc1f/2 mutant cells, suggesting that the hyperexcitability and reduced threshold for eliciting APs may result from changes in the expression…”
BackgroundMethodInfluentialRapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2008) · Annals of Neurology · doi:10.1002/ana.21331 · Cited by 639 · cited 6×
“This may provide a possible explanation for why rapamycin treatment is so effective in our and other TSC epilepsy models.(23,27) However, there are some notable differences in the pathology and seizures in our inducible Tsc1 mice compared to previously described TSC epilepsy models.”
BackgroundResultInfluentialRheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483 · cited 1×
“the small G-protein Ras homolog enriched in brain (RHEB), an essential activator of the target of rapamycin complex 1 (TORC1).(2) TORC1 is a major regulator of cell growth and proliferation, and TSC is characterized by the development of benign tumor-like lesions in different organs, most of which show increased TORC1…”
BackgroundMeikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462 · cited 7×
“This may provide a possible explanation for why rapamycin treatment is so effective in our and other TSC epilepsy models.(23,27) However, there are some notable differences in the pathology and seizures in our inducible Tsc1 mice compared to previously described TSC epilepsy models.”
BackgroundResultInfluentialmTOR: A pathogenic signaling pathway in developmental brain malformations
Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266 · cited 1×
“For instance, increased TORC1 activity has been implicated in focal cerebral cortical malformations, which are the most common cause of medically intractable epilepsy in children.(14) Increased TORC1 activity has also been demonstrated in classic rodent models of acquired epilepsy.”
BackgroundLoss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function
Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., & Sabatini, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1617-11.2011 · Cited by 204 · cited 1×
“Nonetheless, these neurons showed increased excitatory currents, indicating that Tsc1 may play a direct role in maintaining synaptic strength and preventing epilepsy.(12) Emerging evidence suggests that TORC1 may be an important general regulator for epilepsy, not just in TSC.”
BackgroundBiallelic TSC gene inactivation in tuberous sclerosis complex
Crino, P. B., Aronica, E., Baltuch, G., & Nathanson, K. L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04325 · Cited by 153
Cited by
mTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737
Lipton, J. O., & Sahin, M. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.034 · Cited by 736
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368
LaSarge, C. L., & Danzer, S. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00018 · Cited by 189
“Finally, recent work by Abs et al. (2013) produced the intriguing result that global deletion of TSC1 from adult animals could result in the onset of spontaneous seizures within 2–9 days.”
BackgroundInfluentialEpilepsy in the mTORopathies: opportunities for precision medicine
Moloney, P. B., Cavalleri, G. L., & Delanty, N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab222 · Cited by 125
Winden, K. D., Sundberg, M., Yang, C., Wafa, S. M. A., Dwyer, S., Chen, P.-F., Buttermore, E. D., & Sahin, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0642-19.2019 · Cited by 93
“These data are consistent with a prior study that showed that deletion of Tsc1 in adult mice led to hyperexcitability (Abs et al., 2013).”
BackgroundResultReijnders, M. R. F., Kousi, M., van Woerden, G. M., Klein, M., Bralten, J., Mancini, G. M. S., van Essen, T., Proietti-Onori, M., Smeets, E. E. J., van Gastel, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00933-6 · Cited by 76
Metadata
- Authors
- Abs, E., Goorden, S. M. I., Schreiber, J., Overwater, I. E., Hoogeveen‐Westerveld, M., Bruinsma, C. F., Aganović, E., Borgesius, N. Z., Nellist, M., & Elgersma, Y.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-09-10
- Volume
- 74
- Issue
- 4
- Pages
- 569-579
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1565060794
- Cited by
- 81
- References
- 11
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.